The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
NAVIGATE-PCI
1 other identifier
observational
5,000
1 country
1
Brief Summary
The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2026
CompletedStudy Start
First participant enrolled
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
March 23, 2026
March 1, 2026
7 months
March 11, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Endpoint
The primary endpoint will be assessed only in Group 2 and is a change in procedural plan following review of the information provided by PCI Navigator compared to procedural plan with angiographic imaging alone. The primary endpoint will be measured by calculating the percentage of patients in whom a change of plan was documented following review of the PCI Navigator tool compared to the plan documented prior to using the tool.
90 Days
Secondary Outcomes (6)
Changes in confidence with and without PCI Navigator (assessed in Groups 2 and 3 as two separate analyses)
90 days for Group 2, 18 months for Group 3
Change in procedural time with and without PCI Navigator
90 days
Change in contrast usage with and without PCI Navigator
90 days
Change in radiation usage during PCI with and without PCI Navigator
90 days
Change in invasive imaging (angiographic or other) with and without PCI Navigator
90 days
- +1 more secondary outcomes
Other Outcomes (2)
Exploratory and Safety Endpoint
5 years
Exploratory and Safety Endpoint
5 years
Study Arms (3)
Group 1: No PCI Navigator
This group includes consecutive patients who have undergone a CCTA a maximum of 90 days prior to an elective PCI at the study site; the CCTA is not required to have been used in procedural planning but must have acceptable image quality according to Heartflow's image quality requirements
Group 2: Intraprocedural PCI Planning
This group includes patients who had a CCTA and a referral for elective PCI following the introduction of the PCI Navigator at the study site. The PCI should be performed no more than 90 days following the CCTA. Interventionalists will document their procedural plan after initial invasive angiographic images are reviewed but before reviewing the information provided by the PCI Navigator, and then again after reviewing the information provided by the PCI Navigator. Usage of invasive imaging following review of the PCI Navigator is at the discretion of the interventionalist.
Group 3: Preprocedural Planning
This group includes patients who had a CCTA and a referral for elective PCI following the introduction of the PCI Navigator at the study site. The PCI should be performed no more than 90 days following the CCTA. Interventionalists will document their procedural plan before reviewing the information provided by the PCI Navigator and prior to initial invasive angiographic imaging, and then again after reviewing the information provided by the PCI Navigator. Usage of angiographic and other invasive imaging following review of the PCI Navigator is at the discretion of the interventionalist.
Interventions
Heartflow PCI Navigator is the only integrated, AI-driven PCI planning tool that gives interventional cardiologists a patient-specific 3D model, detailing anatomy, plaque composition, and lesion-specific physiology, all aligned to optimize potential stent placement. PCI Navigator delivers a streamlined view of essential information for cath lab decision-making by integrating all relevant measurements, including IVUS-like and FFR-like pullback visualizations, into one seamless experience, which typically requires significant time and effort to obtain in the cath lab.
Eligibility Criteria
Deidentified data will be collected for all patients included in the registry who had a CCTA with acceptable image quality prior to elective PCI and are included by the site in the registry. Patients with prior CABG or patients with intervention planned in a previously stented vessel territory are excluded.
You may qualify if:
- CCTA completed ≤90 days prior to elective PCI with acceptable image quality according to Heartflow's image quality requirements
- Referred for elective PCI
- Clinically stable without symptoms suggestive of acute coronary syndrome (ACS) at the time of the intervention
You may not qualify if:
- ED presentation (at the time of the referral for PCI)
- Previous coronary artery bypass graft (CABG)
- Planned intervention in a previously stented vessel territory
- Acute chest pain (in patients who have not been ruled out for ACS)
- Participating in a conflicting study being undertaken during the PCI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HeartFlow, Inc.lead
Study Sites (1)
Wellstar Health System
Marietta, Georgia, 30060, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ziad Ali, MD, DPhil
St. Francis Hospital & Heart Center Columbia University
- PRINCIPAL INVESTIGATOR
Todd C. Villines, MD
University of Virginia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 18, 2026
Study Start
March 11, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
December 31, 2032
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share